Publikationen in Zusammenarbeit mit Forschern von Hospital Infantil Universitario Niño Jesus de Madrid (177)

2024

  1. Artificial intelligence chatbots: Are they a reliable source for patients and families in pediatric neuro-oncology?

    Pediatric Blood and Cancer

  2. Chemotherapy in pediatric low-grade gliomas (PLGG)

    Child's Nervous System

  3. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study

    The Lancet Oncology, Vol. 25, Núm. 5, pp. 668-682

  4. Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry

    Pediatric Rheumatology , Vol. 22, Núm. 1

  5. Continuous response despite reduced dose of trametinib as single agent in an adolescent with a relapsed disseminated pediatric low-grade glioma KIAA1549-BRAF fusion positive: a case report and review of the literature

    Frontiers in Oncology, Vol. 14

  6. ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer

    Clinical and Translational Oncology, Vol. 26, Núm. 9, pp. 2351-2359

  7. Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngioma

    Frontiers in Oncology, Vol. 14

  8. Impaired high-density lipoprotein function and endothelial barrier stability in severe anaphylaxis

    Journal of Allergy and Clinical Immunology, Vol. 154, Núm. 3, pp. 827-832

  9. L-serine treatment in patients with GRIN-related encephalopathy: A phase 2A, non-randomized study

    Brain, Vol. 147, Núm. 5, pp. 1653-1666

  10. Palliative care for children with central nervous system tumors: results of a Spanish multicenter study

    Clinical and Translational Oncology, Vol. 26, Núm. 3, pp. 786-795

  11. Re-irradiation for progressive Diffuse Intrinsic Pontine Glioma (DIPG): The Spanish experience

    EJC Paediatric Oncology, Vol. 4

  12. Safety and outcome of children, adolescents and young adults participating in phase I/II clinical oncology trials: a 9-year center experience

    Frontiers in Pediatrics, Vol. 12